EFSA (European Food Safety Authority) scientists currently cannot establish the safety of cannabidiol (CBD) due to data gaps and uncertainties about potential hazards related to intake. Cannabidiol is a substance obtained from the Cannabis sativa L plant. The European Commission considers it as a novel food provided it meets the conditions of EU legislation and has asked ESFA to provide an opinion as to whether consumption is safe for humans. To date, EFSA’s expert panel has received 19 applications for CBD as a novel food with more requests in the pipeline. There is insufficient safety data for effects on the liver, endocrine system, nervous system, and general well-being. The novel foods evaluations are on hold pending additional safety data, and applicants are invited to an information session on June 28^th.

Interested in regulatory updates? Check out our – CBD Automated Digest

Posted on 15 June 2022